• A novel regulatory mechanism for human interferon lambda has been defined

  • A new graduate student begins her work towards an M.S. at HUMIGEN, graduation expected 2013

  • HUMIGEN opens two new research laboratories, in Lymphocyte Signaling and Cellular Immunology

  • HUMIGEN begins recruiting SLE patients for a novel biomarker discovery study

  • A HUMIGEN Research Associate graduates May 2011 with an M.S. in Molecular Pathology and Immunology

  • HUMIGEN begins recruiting asthma patients for a novel biomarker discovery study

  • A new soluble variant of the human IL-23 receptor inhibits the development of human Th17 cells

  • Two graduate students are working towards their M.S. in HUMIGEN, graduation expected 2012

  • HUMIGEN begins recruiting IBD patients for a novel biomarker discovery study

  • A novel feedback loop between the Th2 response and interferon lambda is mediated by monocytes

  • A new Ph.D. student begins work in HUMIGEN research laboratories

Home Research Laboratories Clinical Studies Publications Abstracts & Presentations Collaboration Careers M.S. Program Delta – 9 Genesis

Research Laboratories


Research at HUMIGEN is currently focused  in three research laboratories, whose translational goals lie in the discovery of novel biomarkers and therapeutic approaches:  

Genetic Immunology Laboratory:

The Genetic Immunology Laboratory is led by Dr Grant Gallagher. The laboratory specialises in translational research into asthma and IBD, pregnancy and implantation, and colorectal cancer and metastasis, with particular emphasis on the role of the Th17 and Th2 responses. The Genetic Immunology Laboratory maintains  basic research interests in Interferon lambda and interleukin-19, and their regulation.

 

Lymphocyte Signaling Laboratory:

The Lymphocyte Signaling Laboratory is led by Dr Nithianadan Selliah. The laboratory specialises in translational research into SLE, with particular emphasis on the role of T-cell signaling pathways. The Lymphocyte Signaling Laboratory maintains basic research interests in signaling processes in prostate cancer and IBD.

 

Cellular Immunology Laboratory:

The Cellular Immunology Laboratory is led by Dr Nicholas Megjugorac. The laboratory specialises in translational research into IBD and prostate cancer, with particular emphasis on biomarker development and the role of IL-17 in regulating inflammatory responses. The Cellular Immunology Laboratory maintains basic research interests in the role of plasmacytoid dendritic cells and T-cell regulation.